Jules Angst

Last updated
Jules Angst
Born (1926-12-11) 11 December 1926 (age 96) [1]
NationalitySwiss
Citizenship Switzerland
Alma mater University of Zurich
AwardsAnna Monika Awards (1967/1969),
Paul Martini Prize for Methodology in Medicine (1969),
Otto Naegeli Prize (1983),
Eric Stromgren Medal (1987),
the Emil Kraepelin Medal of the Max Planck Institute, Munich (1992)
Selo Prize NARSAD/Depression Research, USA (1994),
Mogens Schou Award for Research in Bipolar Disorder, USA (2001),
Burgholzli Award for Social Psychiatry (2001),
Lifetime Achievement Award of the International Society of Psychiatric Genetics (2002),
Lifetime Achievement Award (European Bipolar Forum),
Wagner-Jauregg Medal (2007),
ECNP Lifetime Achievement Award in Neuro-psychopharmacology (2012),
Lifetime Achievement Award of the American Foundation for Suicide Prevention (2013),
Joseph Zubin Award (APPA)(2015),
Jean Delay Prize of the WPA (2017),
Wilhelm Griesinger Medal of the DGPPN (German Association for Psychiatry, Psychotherapy and Psychosomatics) (2018)
Scientific career
Fields psychiatry

Jules Angst (born 11 December 1926) is a Swiss academic who is Emeritus Professor of Psychiatry at Zurich University in Zurich, Switzerland, and Honorary Doctor of Heidelberg University in Heidelberg, Germany.

Contents

Early life

Angst was born in Zurich, where he also grew up. He completed his medical and psychiatric training in Zurich under his mentor, Professor Manfred Bleuler [2] (son and student of Eugen Bleuler). From 1969 to 1994, Jules Angst was Professor of Clinical Psychiatry in the University of Zurich Medical School and Head of the Research Department of Zurich University Psychiatric Hospital (the Burghölzli).

Jules Angst has continued uninterrupted his epidemiological and clinical research at the University (Universitatsklinik) since leaving his Chair. [3] He has remained the President of the European Bipolar Forum since 2003.

His scientific contributions include 15 books (as author and/or editor), 154 book chapters, and 539 journal articles. [4]

Awards

Jules Angst has received many awards in recognition of his work, including the Anna Monika Awards (1967/1969), Paul Martini Prize for Methodology in Medicine (1969), [5] Otto Naegeli Prize (1983), Eric Stromgren Medal (1987), the Emil Kraepelin Medal of the Max Planck Institute, Munich (1992), [6] the Jean Delay Prize of the World Psychiatric Association (2017), [7] and the Wilhelm Griesinger Medal of the DGPPN (German Association for Psychiatry, Psychotherapy and Psychosomatics (2018).

Other awards include the Selo Prize NARSAD/Depression Research, USA (1994), Mogens Schou Award for Research in Bipolar Disorder, USA (2001), [8] Burgholzli Award for Social Psychiatry (2001), the Lifetime Achievement Award of the International Society of Psychiatric Genetics (2002), Lifetime Achievement Award of the European Bipolar Forum (2006), the Wagner-Jauregg Medal (2007), ECNP Lifetime Achievement Award in Neuropsychopharmacology (2012), [9] Lifetime Achievement Award of the American Foundation for Suicide Prevention (2013), [10] and the Joseph Zubin Award of the American Psychopathological Association (2015). [11]

Further reading

Related Research Articles

<span class="mw-page-title-main">Psychiatric medication</span> Medication used to treat mental disorders

A psychiatric or psychotropic medication is a psychoactive drug taken to exert an effect on the chemical makeup of the brain and nervous system. Thus, these medications are used to treat mental illnesses. These medications are typically made of synthetic chemical compounds and are usually prescribed in psychiatric settings, potentially involuntarily during commitment. Since the mid-20th century, such medications have been leading treatments for a broad range of mental disorders and have decreased the need for long-term hospitalization, thereby lowering the cost of mental health care. The recidivism or rehospitalization of the mentally ill is at a high rate in many countries, and the reasons for the relapses are under research.

<span class="mw-page-title-main">Eugen Bleuler</span> Swiss psychiatrist

Paul Eugen Bleuler was a Swiss psychiatrist and humanist most notable for his contributions to the understanding of mental illness. He coined several psychiatric terms including "schizophrenia", "schizoid", "autism", depth psychology and what Sigmund Freud called "Bleuler's happily chosen term ambivalence".

Gordon Barraclough Parker AO is an Australian psychiatrist who is scientia professor of psychiatry at the University of New South Wales (UNSW).

<span class="mw-page-title-main">Hagop S. Akiskal</span> Armenian-American psychiatrist

Hagop Souren Akiskal was a Lebanese-born American psychiatrist and professor, of Armenian descent. He is best known for his research on temperament and bipolar disorder, revolutionizing the field of clinical psychiatry.

Mogens Schou was a Danish psychiatrist whose research into lithium led to its utilization as a treatment for bipolar disorder.

Maximilian Fink is an American neurologist and psychiatrist best known for his work on ECT. His early work also included studies on the effect of psychoactive drugs on brain electrical activity; more recently he has written about the syndromes of catatonia and melancholia.

Frederick King Goodwin was an American psychiatrist and Clinical Professor of Psychiatry at the George Washington University Medical Center, where he was also director of the Center on Neuroscience, Medical Progress, and Society. He was a specialist in bipolar disorder and recurrent depression.

Guy Goodwin is a senior research fellow and until recently was the W.A. Handley Professor of Psychiatry at the University of Oxford (2014). A fellow of the Academy of Medical Sciences, Goodwin has served as principal investigator in many clinical trials for the treatment of bipolar disorder. He is also an Emeritus Senior Investigator at the National Institute for Health and Care Research (NIHR) and has been on the advisory boards of numerous research councils. He was President of the European College of Neuropsychopharmacology from 2013 to 2016.

Johan Cullberg was a Swedish professor in psychiatry and psychology, researcher, psychoanalyst, and author of a number of internationally recognised textbooks.

<span class="mw-page-title-main">Kraepelinian dichotomy</span>

The Kraepelinian dichotomy is the division of the major endogenous psychoses into the disease concepts of dementia praecox, which was reformulated as schizophrenia by Eugen Bleuler by 1908, and manic-depressive psychosis, which has now been reconceived as bipolar disorder. This division was formally introduced in the sixth edition of Emil Kraepelin's psychiatric textbook Psychiatrie. Ein Lehrbuch für Studirende und Aerzte, published in 1899. It has been highly influential on modern psychiatric classification systems, the DSM and ICD, and is reflected in the taxonomic separation of schizophrenia from affective psychosis. However, there is also a diagnosis of schizoaffective disorder to cover cases that seem to show symptoms of both.

Manfred Bleuler was a Swiss physician and psychiatrist. Following in the footsteps of his father, doctoral supervisor, and colleague, Eugen Bleuler, Manfred Bleuler was devoted primarily to the study and treatment of schizophrenia. For his contributions, he received the Stanley R. Dean Award in 1970 and the Marcel Benoist Prize in 1972.

Maria Luisa Figueira is a Portuguese Consultant psychiatrist, psychiatrist and academic known for her research in clinical and experimental psychopathology and psychopharmacology, particularly in relation to bi-polar disorders and schizophrenia. She is Professor of Psychiatry and Director of the Department of Psychiatry at the University of Lisbon Faculty of Medicine and Head of the Psychiatric Department at the Hospital de Santa Maria in Lisbon.

<span class="mw-page-title-main">Eduard Vieta</span> Spanish psychiatrist (born 1963)

Eduard Vieta Pascual is a Spanish psychiatrist and a leading scientific authority on the neurobiology and treatment of bipolar disorder.

Augustus John Rush is an internationally renowned psychiatrist. He is a professor emeritus in Duke-NUS Medical School at the National University of Singapore (NUS), and adjunct professor of psychiatry and behavioral sciences at Duke University School of Medicine. He has authored and edited more than 10 books, and over 600 scientific journal articles that are largely focused on the diagnosis and treatment of depressive and bipolar disorders.

Hilary Patricia Blumberg is a medical doctor and the inaugural John and Hope Furth Professor of Psychiatry at the Yale School of Medicine. She is also a professor of Radiology and Biomedical Imaging, and works in the Child Study Center at Yale where she has been a faculty member since 1998. She attended Harvard University as an undergraduate, and completed medical school at Cornell University Medical College (1990). She completed her medical internship and psychiatry residency at Cornell University Medical College/New York Hospital, and her neuroimaging fellowship training at Cornell University, Weill Medical College. She has received the 2006 National Alliance for Research in Schizophrenia and Depression (NARSAD) and the Gerald L. Klerman Award for Clinical Research. Blumberg has authored a number of scientific articles that focus on bipolar disorder, neuroimaging, and effects of specific genetic variations, developmental trajectories and structure-function relationships.

Gregor Hasler, M.D. is a Swiss psychiatry researcher, psychiatrist and psychotherapist. He is professor and chair of psychiatry and psychotherapy at the University of Fribourg (Switzerland). His research areas covers stress, depression, bipolar disorders, and eating disorders.

Mauricio Tohen is a Mexican American research psychiatrist, Distinguished Professor, and Chairman of the Department of Psychiatry & Behavioral Sciences at the University of New Mexico. Tohen's research has focused on the epidemiology, outcome, and treatment of bipolar and psychotic disorders, and is especially known for innovating the design of clinical trials and the criteria to determine outcome in such diseases. Tohen has edited several books on his specialties. His social awareness has been noted in the promotion of programs to improve mental health care in areas such as substance abuse, bipolar disorder and schizophrenia.

Glenda Marlene MacQueen was a Canadian medical researcher and medical college professor and administrator. She was vice-dean of the Cumming School of Medicine at the University of Calgary from 2012 to 2019.

Marion Leboyer is a French psychiatrist, university professor and hospital practitioner at the Paris-Est Créteil University (UPEC).

SirDavid Paul Brandes Goldberg is a British academic and social psychiatrist, born Hampstead, London in 1934. He trained at the Maudsley Hospital in South London under Sir Aubrey Lewis and Sir Michael Shepherd before taking a Professorship in Manchester. He later returned to the Maudsley to run the Institute of Psychiatry at King's College London.

References

  1. Kürschners deutscher Gelehrten-Kalender: Volume 1, pg. 53
  2. [ dead link ]
  3. "Annals of General Psychiatry". Archived from the original on 2010-09-17. Retrieved 2009-11-18.
  4. "BioMed Central | Search results for: Angst_J All words All fields (Fu…". Archived from the original on 18 January 2013.
  5. "Paul Martini Foundation / Paul Martini Prize / Prize Winners since 1969". Archived from the original on 2013-01-19. Retrieved 2009-11-18.
  6. "Homepage - Max Planck Society".
  7. "Archived copy" (PDF). Archived from the original (PDF) on 2017-09-24. Retrieved 2017-09-24.{{cite web}}: CS1 maint: archived copy as title (link)
  8. http://www.wpic.pitt.edu/stanley/6thbipconf//Mogens%20Schou%20Awards.htm#Mogens_Schou,_M.D.,_Dr._Med._Sci Archived 2007-08-07 at the Wayback Machine .
  9. "Winner 2012 - Jules Angst".
  10. "Annual Reports". afsp.org. Archived from the original on 2015-01-07.
  11. "APPA: Awards". Archived from the original on 2015-06-07. Retrieved 2017-09-24.